| C09AA09 |
Fosinopril |
Fosicard |
Tablet |
20 |
mg |
30 |
Актавис EАД, България |
15 |
mg |
- |
7.31 |
0.18275 |
7.31 |
25% |
1.82 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1 |
НСР-1226/23.09.2013; НСР-14609/08.12.2017; НСР-16502/17.08.2018 |
02.09.2018 |
08.09.2012 |
|
Заличен |
2118 |
| C09AA09 |
Fosinopril |
Fosinopril-Teva 10 |
Tablet |
10 |
mg |
30 |
Тева Фармасютикълс България ЕООД, България |
15 |
mg |
- |
5.95 |
0.18275 |
3.66 |
25% |
0.91 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1 |
НСР-16154/13.07.2018 |
02.08.2018 |
08.09.2012 |
|
Заличен |
662 |
| C09AA09 |
Fosinopril |
Fosinopril-Teva 20 |
Tablet |
20 |
mg |
30 |
Тева Фармасютикълс България ЕООД, България |
15 |
mg |
- |
7.61 |
0.18275 |
7.31 |
25% |
1.82 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1 |
КЦРР-732/07.06.2012 г.; КЦРР-2839/20.03.2013 г.; НСР-6432/12.06.2015.; НСР-16155/13.07.2018 |
02.08.2018 |
08.09.2012 |
|
Заличен |
1807 |
| C09AA09 |
Fosinopril |
Monopril |
Tablet |
10 |
mg |
28 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
15 |
mg |
- |
7.76 |
0.27913 |
5.21 |
25% |
1.3 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1 |
НСР-944/12.08.2013;КЦРР-1309/21.08.2012 и КП-247/20.11.2013; КП-323/18.06.2015; НСР-10592/12.10.2016 |
02.09.2018 |
08.09.2012 |
|
Активен |
2555 |
| C09AA09 |
Fosinopril |
Monopril |
Tablet |
20 |
mg |
28 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
15 |
mg |
- |
10.42 |
0.27913 |
10.42 |
25% |
2.6 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1 |
НСР-944/12.08.2013Протокол 72/26.06.2014; НСР-2345/13.01.2014 и КП-148/06.04.2015.; НСР-13421/23.05.2017 |
02.09.2018 |
08.09.2012 |
|
Активен |
3737 |
| C09AA10 |
Trandolapril |
C09AA10 Trandolapril |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09AA10 |
Trandolapril |
GOPTEN |
Capsule, hard |
4 |
mg |
28 |
Майлан ЕООД, България |
2 |
mg |
- |
14 |
0.25 |
14 |
25% |
3.5 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
№40/27.08.2009; КЦРР-879/28.06.2012 г.; КП-42/05.03.2015 и НСР-3317/24.04.2014; КП-261/11.05.2015 и НСР-1478/21.10.2013; корекц. НСР-6441/12.06.2015 (допуска предварително изпълнение); НСР-7841/15.01.2016.; НСР-18011/21.02.2019 |
02.04.2019 |
08.09.2012 |
|
Активен |
3913 |
| C09AA10 |
Trandolapril |
GOPTEN |
Capsule, hard |
2 |
mg |
28 |
Mylan Healthcare GmbH, Германия |
2 |
mg |
- |
7.45 |
0.25 |
7 |
25% |
1.75 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
№40/27.08.2009; КЦРР-610/18.05.2012 г.; НСР-815/07.08.2013; НСР-4166/23.07.2014; НСР-4381/07.08.2014; НСР-14457/17.11.2017 |
02.10.2018 |
08.09.2012 |
|
Активен |
2061 |
| C09AA10 |
Trandolapril |
GOPTEN |
Capsule, hard |
0.5 |
mg |
20 |
Mylan Healthcare GmbH, Германия |
2 |
mg |
- |
3.04 |
0.25 |
1.25 |
25% |
0.31 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
№40/27.08.2009; КЦРР-611/18.05.2012 г.; НСР-3035/21.03.2014.; НСР-6539/24.06.2015 и КП-357/25.08.2015.; НСР-7938/28.01.2016. |
02.10.2018 |
08.09.2012 |
|
Активен |
2650 |
| C09AA10 |
Trandolapril |
TENSOTRAN |
Capsule, hard |
2 |
mg |
30 |
Актавис EАД, България |
2 |
mg |
- |
5.46 |
0.182 |
5.46 |
25% |
1.37 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
НСР-1899/27.11.2013; НСР-16623/24.08.2018 |
02.10.2018 |
08.09.2012 |
|
Заличен |
2325 |
| C09AA10 |
Trandolapril |
TRANDOLAPRIL GALEX |
Capsule, hard |
4 |
mg |
28 |
Galex d.d., Словения |
2 |
mg |
- |
8.48 |
0.15143 |
8.48 |
25% |
2.12 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
№ 83/27.05.2010; КЦРР-443/19.04.2012 г.; НСР-540/11.07.2013; НСР-4173/23.07.2014 |
16.08.2014 |
08.09.2012 |
|
Заличен |
1988 |
| C09AA10 |
Trandolapril |
TRANDOLAPRIL GALEX |
Capsule, hard |
2 |
mg |
28 |
Galex d.d., Словения |
2 |
mg |
- |
5.09 |
0.15143 |
4.24 |
25% |
1.06 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
№ 83/27.05.2010; КЦРР-444/19.04.2012 г.; НСР-539/11.07.2013; НСР-2275/13.01.2013 |
16.02.2014 |
08.09.2012 |
|
Заличен |
1987 |
| C09AA13 |
Moexipril hydrochloride |
C09AA13 Moexipril hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09AA13 |
Moexipril |
Moex |
Film coated tablet |
7.5 |
mg |
30 |
UCB Pharma GmbH, Германия |
15 |
mg |
- |
10.67 |
0.66067 |
9.91 |
25% |
2.48 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-6248/21.05.2015; НСР-11374/30.12.2016 |
02.02.2017 |
08.09.2012 |
|
Заличен |
509 |
| C09AA13 |
Moexipril |
Moex |
Film coated tablet |
15 |
mg |
30 |
UCB Pharma GmbH, Германия |
15 |
mg |
- |
19.82 |
0.66067 |
19.82 |
25% |
4.96 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
КЦРР-1126/02.08.2012 г.; НСР-6249/21.05.2015; НСР-11374/30.12.2016 |
02.02.2017 |
08.09.2012 |
|
Заличен |
1348 |
| C09AA15 |
Zofenopril calcium |
C09AA15 Zofenopril calcium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09AA15 |
Zofenopril |
ZOFEN |
Film coated tablet |
30 |
mg |
60 |
Berlin-Chemie AG (Menarini Group), Германия |
30 |
mg |
- |
36.53 |
0.60883 |
36.53 |
25% |
9.13 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-5128/27.11.2014; НСР-13883/25.09.2017; НСР-15714/25.05.2018 |
02.07.2018 |
|
|
Активен |
3390 |
| C09AA15 |
Zofenopril |
ZOFEN |
Film coated tablet |
7.5 |
mg |
60 |
Berlin-Chemie AG (Menarini Group), Германия |
30 |
mg |
- |
18.6 |
0.60883 |
9.13 |
25% |
2.28 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-5127/27.11.2014 |
02.07.2018 |
|
|
Активен |
3389 |
| C09AA15 |
Zofenopril |
ZOFEN |
Film coated tablet |
30 |
mg |
28 |
Berlin-Chemie AG (Menarini Group), Германия |
30 |
mg |
- |
17.33 |
0.60883 |
17.05 |
25% |
4.26 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
HCР-529/11.07.2013; НСР-13588/25.08.2017; НСР-15509/26.04.2018 |
02.07.2018 |
08.09.2012 |
|
Активен |
1974 |
| C09AA15 |
Zofenopril |
ZOFEN |
Film coated tablet |
7.5 |
mg |
28 |
Berlin - Chemie AG, Германия |
30 |
mg |
- |
8.94 |
0.68383 |
4.79 |
25% |
1.2 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 70/ 19.04.2010; 9515/09.06.2016. |
02.07.2016 |
08.09.2012 |
|
Заличен |
33 |
| C09BA02 |
Enalapril maleate; Hydrochlorthiazide |
C09BA02 Enalapril maleate; Hydrochlorthiazide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09BA02 |
Enalapril, Hydrochlorothiazide |
Co-Enalapril-Tchaikapharma |
Tablet |
20 mg /12.5 mg |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
1 |
tabl |
- |
12.28 |
0.23433 |
7.03 |
50% |
3.51 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№25/03.08.2009; № 35/21.08.2009; НСР-5129/27.11.2014; НСР-18342/05.04.2019г. |
02.05.2019 |
08.09.2012 |
|
Активен |
3409 |
| C09BA02 |
Enalapril, Hydrochlorothiazide |
Co-Renapril |
Tablet |
20 mg/12,5 mg |
|
28 |
Актавис EАД, България |
1 |
tabl |
- |
7.76 |
0.23433 |
6.56 |
50% |
3.28 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
|
|
08.09.2012 |
|
Активен |
559 |
| C09BA02 |
Enalapril, Hydrochlorothiazide |
Co-Renitec |
Tablet |
20 mg/12.5 mg |
mg |
28 |
Мерк Шарп и Доум България ЕООД, България |
1 |
tabl |
- |
12.5 |
0.23433 |
6.56 |
50% |
3.28 |
|
I10,I11,I12,I13 |
КЦРР-546/04.05.2012 г.; HCР-208/18.06.2013 |
16.07.2013 |
08.09.2012 |
|
Заличен |
1201 |
| C09BA02 |
Enalapril, Hydrochlorothiazide |
Co-Renitec |
Tablet |
20 mg /12.5 mg |
mg |
14 |
Мерк Шарп и Доум България ЕООД, България |
1 |
tabl |
- |
5.02 |
0.23433 |
3.28 |
50% |
1.64 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№35/21.08.2009 |
|
08.09.2012 |
16.11.2013 |
Активен |
322 |